Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
Date:3/7/2012

NANJING, China, March 7, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2011.

Highlights

  • Total revenue was RMB511.0 million (US$81.2 million) for the fourth quarter of 2011, compared to RMB587.7 million for the same period in 2010. For the full year of 2011, total revenue was RMB2,040.5 million (US$324.2 million), which represented a decrease of 4.7% from RMB2,141.1 million in 2010.
  • Income from operations was RMB1.6 million (US$0.3 million) for the fourth quarter of 2011, compared to RMB62.8 million for the same period in 2010. For the full year of 2011, income from operations was RMB143.5 million (US$22.8 million), which represented a decrease of 34.1% from RMB217.9 million in 2010.
  • Net income attributable to Simcere was RMB42.8 million (US$6.8 million) for the fourth quarter of 2011, compared to RMB58.7 million for the same period in 2010. For the full year of 2011, net income was RMB178.4 million (US$28.3 million), which represented an increase of 3.5% from RMB172.4 million in 2010.
  • Gross margin for the fourth quarter of 2011 was 82.3%, compared to 84.1% for the same period in 2010. For the full year of 2011, gross margin was 83.9%, a decrease from 84.0% in 2010. 
  • "2011 was a challenging year for Simcere," commented Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group. "Factors including changes in certain provincial tendering processes as well as government pricing policies nega
    '/>"/>

    SOURCE Simcere Pharmaceutical Group
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
    2. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2011 Results
    3. Simcere Pharmaceutical Group to Announce Third Quarter 2011 Financial Results on Monday, November 14, 2011
    4. Simceres Iremod Receives SFDA New Drug Approval
    5. Simceres Branded Generic Formulation Biqi Passes EU-GMP Inspection
    6. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
    7. Simcere Pharmaceutical Group to Announce Second Quarter 2011 Financial Results on Tuesday, August 9, 2011
    8. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
    9. Simcere Pharmaceutical Group Filed 2010 Annual Report on Form 20-F
    10. Simcere Announces Recent Progress of Qiangkes Registration
    11. Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , Dec. 23, 2014 Echo Therapeutics, ... device company focused on skin permeation, continuous glucose ... Scott W. Hollander has been appointed Chief ... has more than 20 years of experience in ... and most recently served as Vice President, Business ...
    (Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
    (Date:12/24/2014)... Dec. 23, 2014   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... of the Marketing Authorization Application (MAA) for sebelipase ... the company,s request for accelerated assessment, which has ... time.   The MAA, and the ...
    Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
    ... 11, 2011 Amarin Corporation plc (Nasdaq: AMRN ... on cardiovascular disease, today announced that it has completed its ... at a price to the public of $7.60 per ADS. ... underwriters, over-allotment option, the company sold a total of 13,800,000 ...
    ... CITY, Mo., Jan. 11, 2011 Clients ... Health Solutions, LLC, now have access to a customizable, ... drug claims. Medical Drug Management Service™ (MDMS) is a ... trend management, assist with appropriate and consistent patient care ...
    Cached Medicine Technology:Amarin Announces Successful Completion of Offering of American Depositary Shares 2Amarin Announces Successful Completion of Offering of American Depositary Shares 3DST HealthCare Launches Medical Drug Management Service™ 2DST HealthCare Launches Medical Drug Management Service™ 3
    (Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
    (Date:12/25/2014)... 2014 Parker & Sons, Inc. an ... and affordable quality regarding heating, cooling and plumbing services ... 2014 by the “Queen of Clean” for impressive contractor ... impressive reputation over the years for providing outstanding quality ... of contractor services for both homeowners and businesses. Linda ...
    (Date:12/24/2014)... December 24, 2014 Connie Casad, MD, ... functional medicine advocate with 30 years of practice experience ... evaluate the health benefits of dietary detoxification. The second ... participants following excellent results from test patients who just ... to explain her interest in conducting the study, Dr. ...
    (Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
    (Date:12/24/2014)... 25, 2014 The report “Stivarga (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is a drug which is used in the treatment ... administered and is also prescribed to patients who suffer ... FDA approved is a multi-kinase inhibitor and it blocks ...
    Breaking Medicine News(10 mins):Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
    ... a trend setter of sorts. Now, BT Offices and Vans ... that smoking is banned in the BT premises as well ... Importantly, this move might encourage “anti-smoking” initiatives in other industries ... announcement, which will surely set a precedent. Now this means ...
    ... revealed that although cardiologists are well informed about the possibility ... consequence of eating vegetarian diet, they fail to recommend patients ... // ,With this on one side, studies ... show that they are more than willing to adapt the ...
    ... to tackle any Bird Flu cases. A 10-bedded ward has ... and another 20// bedded ward has been set up at ... patients with avian influenza or bird flu., ,Another step ... food restaurant in the city to obtain chickens from only ...
    ... than famous, is now going to face some competition. Private ... Canada, having garnered enough support from the several provinces in ... the Quebec government, which intended to remove the ban on ... offered to chip in and pick up costs for such ...
    ... or blame all those people who had been telling you ... part for bone strength but is not the only one.,It ... ,As per a recent study which is part of Woman's ... D supplements may not be effective in preventing osteoporosis in ...
    ... are thrice as likely to miscarry during the first three ... // The study is the first of it’s kind to ... pregnancy loss at an early stage. ,Cortisol is ... levels of this hormone serve as a reliable stress indicator. ...
    Cached Medicine News:Health News:Calcium in isolation no good for maintaining bone integrity 2Health News:Early Miscarriage Common In Women Under Stress 2
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
    BD Vacutainer® Fluoride Tubes - Plastic...
    VACUETTE Trace Element tubes - Non-ridged (pull cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
    Medicine Products: